Ashwani Verma Score: 35
Analyst at
UBS,
Bank of America Securities
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+11.8%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
53%
24 W / 21 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
70%
16 W / 7 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
13%
3 W / 20 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
4%
1 W / 22 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
50%
13 W / 13 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
55%
23 W / 19 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
33%
1 W / 2 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jun 03, 2026 |
Legend Biotech Corp - ADR
LEGN
|
BUY |
$49.00
Est. +35%
|
$36.28 | $37.46 |
Pending
|
$35.48
-2.2%
|
| May 26, 2026 |
MapLight Therapeutics, Inc.
MPLT
|
BUY |
$48.00
Est. +63%
|
$29.46 | $31.25 |
Pending
|
$27.75
-5.8%
|
| May 19, 2026 |
Jazz Pharmaceuticals plc
JAZZ
|
BUY |
$307.00
Est. +34%
|
$229.55 | $243.32 |
Pending
|
$230.59
+0.5%
|
| Apr 21, 2026 |
Royalty Pharma plc - Ordinary Shares - Class A
RPRX
|
BUY |
$57.00
Est. +16%
|
$49.30 | $56.50 |
Bullseye Hit (±1%)
|
$54.27
+10.1%
|
| Apr 17, 2026 |
Amneal Pharmaceuticals Inc - Ordinary Shares - Class A
AMRX
|
BUY |
$19.00
Est. +45%
|
$13.09 | $16.61 |
Pending
|
$16.24
+24.1%
|
| Mar 06, 2026 |
Cytokinetics Inc
CYTK
|
BUY |
$69.00
Est. +14%
|
$60.59 | $80.18 |
Target Met
|
$71.38
+17.8%
|
| Feb 09, 2026 |
Viatris Inc
VTRS
|
BUY |
$18.00
Est. +23%
|
$14.58 | $17.53 |
Precision Hit (±3%)
|
$16.32
+11.9%
|
| Jan 30, 2026 |
Royalty Pharma plc - Ordinary Shares - Class A
RPRX
|
BUY |
$49.00
Est. +20%
|
$40.86 | $56.50 |
Target Met
|
$54.27
+32.8%
|
| Jan 06, 2026 |
Acadia Pharmaceuticals Inc
ACAD
|
BUY |
$40.00
Est. +50%
|
$26.66 | $27.81 |
Pending
|
$21.27
-20.2%
|
| Jan 05, 2026 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$188.00
Est. +37%
|
$137.15 | $169.57 |
Pending
|
$159.51
+16.3%
|
| Dec 16, 2025 |
Corcept Therapeutics Inc
CORT
|
BUY |
$95.00
Est. +9%
|
$87.30 | $86.58 |
Pending
|
$83.12
-4.8%
|
| Dec 08, 2025 |
Legend Biotech Corp - ADR
LEGN
|
BUY |
$48.00
Est. +71%
|
$28.13 | $37.46 |
Pending
|
$35.48
+26.1%
|
| Dec 04, 2025 |
Acadia Pharmaceuticals Inc
ACAD
|
BUY |
$35.00
Est. +33%
|
$26.22 | $28.35 |
Pending
|
$21.27
-18.9%
|
| Dec 01, 2025 |
Cytokinetics Inc
CYTK
|
SELL |
$61.00
Est. +9%
|
$67.24 | $58.43 (Low) |
Target Met
|
$71.38
-6.2%
|
| Nov 24, 2025 |
Jazz Pharmaceuticals plc
JAZZ
|
BUY |
$188.00
Est. +6%
|
$176.93 | $243.32 |
Target Met
|
$230.59
+30.3%
|
| Oct 28, 2025 |
Avadel Pharmaceuticals plc
AVDL
|
BUY |
$20.00
Est. +8%
|
$18.56 | $23.57 |
Target Met
|
$21.64
+16.6%
|
| Oct 09, 2025 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$195.00
Est. +40%
|
$139.49 | $169.57 |
Pending
|
$159.51
+14.4%
|
| Aug 08, 2025 |
Acadia Pharmaceuticals Inc
ACAD
|
BUY |
$36.00
Est. +47%
|
$24.51 | $28.35 |
Pending
|
$21.27
-13.2%
|
| Jul 11, 2025 |
Exelixis Inc
EXEL
|
SELL |
$43.00
Est. +4%
|
$44.86 | $33.76 (Low) |
Target Met
|
$53.00
-18.1%
|
| Jul 02, 2025 |
Legend Biotech Corp - ADR
LEGN
|
BUY |
$54.00
Est. +50%
|
$35.91 | $45.30 |
Pending
|
$35.48
-1.2%
|
| Jun 17, 2025 |
Alkermes plc
ALKS
|
BUY |
$42.00
Est. +41%
|
$29.77 | $45.76 |
Target Met
|
$44.36
+49.0%
|
| Apr 24, 2025 |
Coherus Biosciences Inc
CHRS
|
BUY |
$1.05
Est. 0%
|
$1.05 | $2.62 |
Target Met
|
$1.36
+29.5%
|
| Jan 08, 2025 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$162.00
Est. +18%
|
$137.55 | $160.18 |
Precision Hit (±3%)
|
$159.51
+16.0%
|
| Dec 18, 2024 |
Teva- Pharmaceutical Industries Ltd. - ADR
TEVA
|
BUY |
$28.00
Est. +32%
|
$21.20 | $30.44 |
Target Met
|
$33.69
+58.9%
|
| Oct 03, 2024 |
Biogen Inc
BIIB
|
BUY |
$202.00
Est. +7%
|
$188.74 | $194.13 |
Miss
|
$198.64
+5.2%
|
| Sep 19, 2024 |
Exelixis Inc
EXEL
|
BUY |
$30.00
Est. +12%
|
$26.82 | $49.40 |
Target Met
|
$53.00
+97.6%
|
| Sep 10, 2024 |
Harmony Biosciences Holdings Inc
HRMY
|
BUY |
$56.00
Est. +52%
|
$36.89 | $41.61 |
Miss
|
$34.18
-7.3%
|
| Sep 03, 2024 |
Teva- Pharmaceutical Industries Ltd. - ADR
TEVA
|
BUY |
$26.00
Est. +41%
|
$18.43 | $22.80 |
Miss
|
$33.69
+82.8%
|
| Jul 10, 2024 |
Teva- Pharmaceutical Industries Ltd. - ADR
TEVA
|
BUY |
$24.00
Est. +52%
|
$15.81 | $22.80 |
Miss
|
$33.69
+113.1%
|
| Jul 08, 2024 |
United Therapeutics Corp
UTHR
|
BUY |
$370.00
Est. +17%
|
$317.18 | $417.82 |
Target Met
|
$549.57
+73.3%
|
| Jun 25, 2024 |
Intra-Cellular Therapies Inc
ITCI
|
BUY |
$83.00
Est. +15%
|
$72.42 | $131.98 |
Target Met
|
$131.87
+82.1%
|
| Jun 03, 2024 |
Royalty Pharma plc - Ordinary Shares - Class A
RPRX
|
BUY |
$28.00
Est. +2%
|
$27.35 | $34.31 |
Target Met
|
$54.27
+98.4%
|
| May 28, 2024 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$193.00
Est. +38%
|
$139.40 | $157.98 |
Miss
|
$159.51
+14.4%
|
| Apr 30, 2024 |
Acadia Pharmaceuticals Inc
ACAD
|
BUY |
$27.00
Est. +58%
|
$17.10 | $20.67 |
Miss
|
$21.27
+24.4%
|
| Mar 12, 2024 |
Acadia Pharmaceuticals Inc
ACAD
|
BUY |
$33.00
Est. +65%
|
$19.98 | $20.67 |
Miss
|
$21.27
+6.4%
|
| Nov 09, 2022 |
Viatris Inc
VTRS
|
BUY |
$12.00
Est. +11%
|
$10.83 | - | - |
$16.32
+50.7%
|
| Jul 05, 2022 |
Horizon Therapeutics Plc
HZNP
|
BUY |
$137.00
Est. +69%
|
$80.84 | - | - |
$116.30
+43.9%
|
| Jun 13, 2022 |
Viatris Inc
VTRS
|
SELL |
$9.00
Est. +16%
|
$10.77 | - | - |
$16.32
-51.5%
|
| Jun 13, 2022 |
Jazz Pharmaceuticals plc
JAZZ
|
BUY |
$194.00
Est. +37%
|
$141.59 | - | - |
$230.59
+62.9%
|
| Jun 13, 2022 |
Teva- Pharmaceutical Industries Ltd. - ADR
TEVA
|
BUY |
$10.00
Est. +27%
|
$7.89 | - | - |
$33.69
+327.0%
|
| Jun 13, 2022 |
Royalty Pharma plc - Ordinary Shares - Class A
RPRX
|
BUY |
$47.00
Est. +22%
|
$38.46 | - | - |
$54.27
+41.1%
|
| Jun 13, 2022 |
Horizon Therapeutics Plc
HZNP
|
BUY |
$139.00
Est. +70%
|
$81.60 | - | - |
$116.30
+42.5%
|
| Jun 13, 2022 |
Intra-Cellular Therapies Inc
ITCI
|
BUY |
$75.00
Est. +41%
|
$53.07 | - | - |
$131.87
+148.5%
|
| Jun 13, 2022 |
Coherus Biosciences Inc
CHRS
|
BUY |
$7.00
Est. +13%
|
$6.19 | - | - |
$1.36
-78.0%
|
| Aug 10, 2021 |
Axsome Therapeutics Inc
AXSM
|
BUY |
$25.00
Est. +5%
|
$23.78 | - | - |
$253.40
+965.6%
|
Legend Biotech Corp - ADR
LEGN
Jun 03, 2026
Signal & Target
BUY
$49.00
Start Price
$36.28
Best Price (1Y)
$37.46
Current Price
$35.48
Return
-2.2%
MapLight Therapeutics, Inc.
MPLT
May 26, 2026
Signal & Target
BUY
$48.00
Start Price
$29.46
Best Price (1Y)
$31.25
Current Price
$27.75
Return
-5.8%
Jazz Pharmaceuticals plc
JAZZ
May 19, 2026
Signal & Target
BUY
$307.00
Start Price
$229.55
Best Price (1Y)
$243.32
Current Price
$230.59
Return
+0.5%
Royalty Pharma plc - Ordinary Shares - Class A
RPRX
Apr 21, 2026
Signal & Target
BUY
$57.00
Start Price
$49.30
Best Price (1Y)
$56.50
Current Price
$54.27
Return
+10.1%
Signal & Target
BUY
$19.00
Start Price
$13.09
Best Price (1Y)
$16.61
Current Price
$16.24
Return
+24.1%
Cytokinetics Inc
CYTK
Mar 06, 2026
Signal & Target
BUY
$69.00
Start Price
$60.59
Best Price (1Y)
$80.18
Current Price
$71.38
Return
+17.8%
Viatris Inc
VTRS
Feb 09, 2026
Signal & Target
BUY
$18.00
Start Price
$14.58
Best Price (1Y)
$17.53
Current Price
$16.32
Return
+11.9%
Royalty Pharma plc - Ordinary Shares - Class A
RPRX
Jan 30, 2026
Signal & Target
BUY
$49.00
Start Price
$40.86
Best Price (1Y)
$56.50
Current Price
$54.27
Return
+32.8%
Acadia Pharmaceuticals Inc
ACAD
Jan 06, 2026
Signal & Target
BUY
$40.00
Start Price
$26.66
Best Price (1Y)
$27.81
Current Price
$21.27
Return
-20.2%
Neurocrine Biosciences, Inc.
NBIX
Jan 05, 2026
Signal & Target
BUY
$188.00
Start Price
$137.15
Best Price (1Y)
$169.57
Current Price
$159.51
Return
+16.3%
Corcept Therapeutics Inc
CORT
Dec 16, 2025
Signal & Target
BUY
$95.00
Start Price
$87.30
Best Price (1Y)
$86.58
Current Price
$83.12
Return
-4.8%
Legend Biotech Corp - ADR
LEGN
Dec 08, 2025
Signal & Target
BUY
$48.00
Start Price
$28.13
Best Price (1Y)
$37.46
Current Price
$35.48
Return
+26.1%
Acadia Pharmaceuticals Inc
ACAD
Dec 04, 2025
Signal & Target
BUY
$35.00
Start Price
$26.22
Best Price (1Y)
$28.35
Current Price
$21.27
Return
-18.9%
Cytokinetics Inc
CYTK
Dec 01, 2025
Signal & Target
SELL
$61.00
Start Price
$67.24
Best Price (1Y)
$58.43
Current Price
$71.38
Return
-6.2%
Jazz Pharmaceuticals plc
JAZZ
Nov 24, 2025
Signal & Target
BUY
$188.00
Start Price
$176.93
Best Price (1Y)
$243.32
Current Price
$230.59
Return
+30.3%
Avadel Pharmaceuticals plc
AVDL
Oct 28, 2025
Signal & Target
BUY
$20.00
Start Price
$18.56
Best Price (1Y)
$23.57
Current Price
$21.64
Return
+16.6%
Neurocrine Biosciences, Inc.
NBIX
Oct 09, 2025
Signal & Target
BUY
$195.00
Start Price
$139.49
Best Price (1Y)
$169.57
Current Price
$159.51
Return
+14.4%
Acadia Pharmaceuticals Inc
ACAD
Aug 08, 2025
Signal & Target
BUY
$36.00
Start Price
$24.51
Best Price (1Y)
$28.35
Current Price
$21.27
Return
-13.2%
Exelixis Inc
EXEL
Jul 11, 2025
Signal & Target
SELL
$43.00
Start Price
$44.86
Best Price (1Y)
$33.76
Current Price
$53.00
Return
-18.1%
Legend Biotech Corp - ADR
LEGN
Jul 02, 2025
Signal & Target
BUY
$54.00
Start Price
$35.91
Best Price (1Y)
$45.30
Current Price
$35.48
Return
-1.2%
Alkermes plc
ALKS
Jun 17, 2025
Signal & Target
BUY
$42.00
Start Price
$29.77
Best Price (1Y)
$45.76
Current Price
$44.36
Return
+49.0%
Coherus Biosciences Inc
CHRS
Apr 24, 2025
Signal & Target
BUY
$1.05
Start Price
$1.05
Best Price (1Y)
$2.62
Current Price
$1.36
Return
+29.5%
Neurocrine Biosciences, Inc.
NBIX
Jan 08, 2025
Signal & Target
BUY
$162.00
Start Price
$137.55
Best Price (1Y)
$160.18
Current Price
$159.51
Return
+16.0%
Teva- Pharmaceutical Industries Ltd. - ADR
TEVA
Dec 18, 2024
Signal & Target
BUY
$28.00
Start Price
$21.20
Best Price (1Y)
$30.44
Current Price
$33.69
Return
+58.9%
Biogen Inc
BIIB
Oct 03, 2024
Signal & Target
BUY
$202.00
Start Price
$188.74
Best Price (1Y)
$194.13
Current Price
$198.64
Return
+5.2%
Exelixis Inc
EXEL
Sep 19, 2024
Signal & Target
BUY
$30.00
Start Price
$26.82
Best Price (1Y)
$49.40
Current Price
$53.00
Return
+97.6%
Harmony Biosciences Holdings Inc
HRMY
Sep 10, 2024
Signal & Target
BUY
$56.00
Start Price
$36.89
Best Price (1Y)
$41.61
Current Price
$34.18
Return
-7.3%
Teva- Pharmaceutical Industries Ltd. - ADR
TEVA
Sep 03, 2024
Signal & Target
BUY
$26.00
Start Price
$18.43
Best Price (1Y)
$22.80
Current Price
$33.69
Return
+82.8%
Teva- Pharmaceutical Industries Ltd. - ADR
TEVA
Jul 10, 2024
Signal & Target
BUY
$24.00
Start Price
$15.81
Best Price (1Y)
$22.80
Current Price
$33.69
Return
+113.1%
United Therapeutics Corp
UTHR
Jul 08, 2024
Signal & Target
BUY
$370.00
Start Price
$317.18
Best Price (1Y)
$417.82
Current Price
$549.57
Return
+73.3%
Intra-Cellular Therapies Inc
ITCI
Jun 25, 2024
Signal & Target
BUY
$83.00
Start Price
$72.42
Best Price (1Y)
$131.98
Current Price
$131.87
Return
+82.1%
Royalty Pharma plc - Ordinary Shares - Class A
RPRX
Jun 03, 2024
Signal & Target
BUY
$28.00
Start Price
$27.35
Best Price (1Y)
$34.31
Current Price
$54.27
Return
+98.4%
Neurocrine Biosciences, Inc.
NBIX
May 28, 2024
Signal & Target
BUY
$193.00
Start Price
$139.40
Best Price (1Y)
$157.98
Current Price
$159.51
Return
+14.4%
Acadia Pharmaceuticals Inc
ACAD
Apr 30, 2024
Signal & Target
BUY
$27.00
Start Price
$17.10
Best Price (1Y)
$20.67
Current Price
$21.27
Return
+24.4%
Acadia Pharmaceuticals Inc
ACAD
Mar 12, 2024
Signal & Target
BUY
$33.00
Start Price
$19.98
Best Price (1Y)
$20.67
Current Price
$21.27
Return
+6.4%
Viatris Inc
VTRS
Nov 09, 2022
Signal & Target
BUY
$12.00
Start Price
$10.83
Best Price (1Y)
-
Current Price
$16.32
Return
+50.7%
Horizon Therapeutics Plc
HZNP
Jul 05, 2022
Signal & Target
BUY
$137.00
Start Price
$80.84
Best Price (1Y)
-
Current Price
$116.30
Return
+43.9%
Viatris Inc
VTRS
Jun 13, 2022
Signal & Target
SELL
$9.00
Start Price
$10.77
Best Price (1Y)
-
Current Price
$16.32
Return
-51.5%
Jazz Pharmaceuticals plc
JAZZ
Jun 13, 2022
Signal & Target
BUY
$194.00
Start Price
$141.59
Best Price (1Y)
-
Current Price
$230.59
Return
+62.9%
Teva- Pharmaceutical Industries Ltd. - ADR
TEVA
Jun 13, 2022
Signal & Target
BUY
$10.00
Start Price
$7.89
Best Price (1Y)
-
Current Price
$33.69
Return
+327.0%
Royalty Pharma plc - Ordinary Shares - Class A
RPRX
Jun 13, 2022
Signal & Target
BUY
$47.00
Start Price
$38.46
Best Price (1Y)
-
Current Price
$54.27
Return
+41.1%
Horizon Therapeutics Plc
HZNP
Jun 13, 2022
Signal & Target
BUY
$139.00
Start Price
$81.60
Best Price (1Y)
-
Current Price
$116.30
Return
+42.5%
Intra-Cellular Therapies Inc
ITCI
Jun 13, 2022
Signal & Target
BUY
$75.00
Start Price
$53.07
Best Price (1Y)
-
Current Price
$131.87
Return
+148.5%
Coherus Biosciences Inc
CHRS
Jun 13, 2022
Signal & Target
BUY
$7.00
Start Price
$6.19
Best Price (1Y)
-
Current Price
$1.36
Return
-78.0%
Axsome Therapeutics Inc
AXSM
Aug 10, 2021
Signal & Target
BUY
$25.00
Start Price
$23.78
Best Price (1Y)
-
Current Price
$253.40
Return
+965.6%